We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

43 hedge funds and large institutions have $68.9M invested in Protara Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

4% less funds holding

Funds holding: 45 → 43 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

51% less capital invested

Capital invested by funds: $141M → $68.9M (-$71.8M)

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
2
Increased
12
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$1.21M
2
State Street
State Street
Massachusetts
+$282K
3
Baird Financial Group
Baird Financial Group
Wisconsin
+$161K
4
Deutsche Bank
Deutsche Bank
Germany
+$37.4K
5
Citigroup
Citigroup
New York
+$29.3K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.86M
2
MIM
Monashee Investment Management
Massachusetts
-$508K
3
TAM
Tiverton Asset Management
Delaware
-$319K
4
BFA
BlackRock Fund Advisors
California
-$89.6K
5
Morgan Stanley
Morgan Stanley
New York
-$31.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$15.6M – – –
RCM
2
RA Capital Management
Massachusetts
$12.6M +$1.21M +3,750 +10%
DM
3
Deerfield Management
New York
$9.79M – – –
MAM
4
MPM Asset Management
Massachusetts
$7.61M – – –
Fidelity Investments
5
Fidelity Investments
Massachusetts
$4.8M -$1.86M -5,756 -27%
DVC
6
Deer VII & Co
New York
$2.44M – – –
BBA
7
Baker Bros. Advisors
New York
$2.31M – – –
PA
8
Perceptive Advisors
New York
$2.13M – – –
TAM
9
Tiverton Asset Management
Delaware
$2.05M -$319K -989 -13%
OFM
10
Omega Fund Management
Massachusetts
$1.94M – – –
BFA
11
BlackRock Fund Advisors
California
$1.5M -$89.6K -278 -5%
Principal Financial Group
12
Principal Financial Group
Iowa
$1.46M -$10.3K -32 -0.7%
Vanguard Group
13
Vanguard Group
Pennsylvania
$1.15M +$4.51K +14 +0.4%
State Street
14
State Street
Massachusetts
$729K +$282K +874 +59%
Northern Trust
15
Northern Trust
Illinois
$621K +$6.45K +20 +1%
BIT
16
BlackRock Institutional Trust
California
$398K -$6.12K -19 -1%
BIM
17
BlackRock Investment Management
Delaware
$201K +$3.87K +12 +2%
TCIM
18
TIAA CREF Investment Management
New York
$154K – – –
Baird Financial Group
19
Baird Financial Group
Wisconsin
$154K +$161K +498 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$152K – – –
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$127K +$16.8K +52 +15%
MIM
22
Monashee Investment Management
Massachusetts
$113K -$508K -1,577 Closed
MPM
23
Meritage Portfolio Management
Kansas
$111K – – –
KCM
24
Kornitzer Capital Management
Kansas
$93K – – –
BCM
25
Bridgeway Capital Management
Texas
$92K – – –
1
2

TARA Hedge Fund Activity: Q1 2016 in Review

43 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q1 2016, worth a combined $68.9M — down 51% from $141M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TARA and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 12 added.

The largest buyer was RA Capital Management, adding an estimated $1.21M. The largest seller was Fidelity Investments, cutting an estimated $1.86M.

  • 43 institutional investors held Protara Therapeutics (TARA) as of Q1 2016, down from 45 in Q4 2015.
  • Funds reported $68.9M of Protara Therapeutics stock for Q1 2016, down 51% quarter-over-quarter.
  • 2 funds opened new Protara Therapeutics positions in Q1 2016 and 4 closed out, a net change of -2 holders.
  • The largest Protara Therapeutics buyer in Q1 2016 was RA Capital Management, an estimated $1.21M added.
  • The largest Protara Therapeutics seller in Q1 2016 was Fidelity Investments, an estimated $1.86M sold.

Based on aggregated 13F filings for Q1 2016.